Natural Beauty Bio-Technology Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Natural Beauty Bio-Technology.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 17.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Natural Beauty Bio-Technology Limited's (HKG:157) Shareholders Might Be Looking For Exit
Jul 25
Natural Beauty Bio-Technology Limited's (HKG:157) Share Price Could Signal Some Risk
Jun 07Some Investors May Be Worried About Natural Beauty Bio-Technology's (HKG:157) Returns On Capital
Feb 24Some Investors May Be Worried About Natural Beauty Bio-Technology's (HKG:157) Returns On Capital
Oct 03Investors Could Be Concerned With Natural Beauty Bio-Technology's (HKG:157) Returns On Capital
Mar 09The Returns On Capital At Natural Beauty Bio-Technology (HKG:157) Don't Inspire Confidence
Nov 09Natural Beauty Bio-Technology (HKG:157) Has Some Difficulty Using Its Capital Effectively
Jun 12Is Natural Beauty Bio-Technology (HKG:157) Using Capital Effectively?
Feb 16
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Natural Beauty Bio-Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 331 | -36 | -77 | -26 | N/A |
| 3/31/2024 | 334 | -26 | -62 | -2 | N/A |
| 12/31/2023 | 336 | -15 | -47 | 22 | N/A |
| 9/30/2023 | 335 | -12 | -49 | 23 | N/A |
| 6/30/2023 | 334 | -10 | -50 | 24 | N/A |
| 3/31/2023 | 335 | -20 | -41 | 18 | N/A |
| 12/31/2022 | 336 | -30 | -33 | 12 | N/A |
| 9/30/2022 | 378 | -21 | -5 | 28 | N/A |
| 6/30/2022 | 421 | -12 | 22 | 45 | N/A |
| 3/31/2022 | 454 | 12 | 14 | 45 | N/A |
| 12/31/2021 | 488 | 35 | 7 | 45 | N/A |
| 9/30/2021 | 486 | 33 | -13 | 37 | N/A |
| 6/30/2021 | 485 | 31 | -32 | 30 | N/A |
| 3/31/2021 | 448 | 19 | -38 | 30 | N/A |
| 12/31/2020 | 411 | 8 | -44 | 30 | N/A |
| 9/30/2020 | 400 | 3 | -57 | 29 | N/A |
| 6/30/2020 | 390 | -1 | -70 | 28 | N/A |
| 3/31/2020 | 414 | 10 | -64 | 23 | N/A |
| 12/31/2019 | 438 | 22 | -58 | 19 | N/A |
| 9/30/2019 | 410 | 18 | -50 | 15 | N/A |
| 6/30/2019 | 381 | 14 | -40 | 13 | N/A |
| 3/31/2019 | 375 | 20 | -9 | 44 | N/A |
| 12/31/2018 | 370 | 26 | 22 | 74 | N/A |
| 9/30/2018 | 390 | 61 | 65 | 112 | N/A |
| 6/30/2018 | 410 | 96 | 105 | 147 | N/A |
| 3/31/2018 | 405 | 101 | N/A | 84 | N/A |
| 12/31/2017 | 400 | 105 | N/A | 21 | N/A |
| 9/30/2017 | 409 | 105 | N/A | 9 | N/A |
| 6/30/2017 | 419 | 104 | N/A | -4 | N/A |
| 3/31/2017 | 447 | 126 | N/A | 62 | N/A |
| 12/31/2016 | 475 | 148 | N/A | 128 | N/A |
| 9/30/2016 | 479 | 145 | N/A | 137 | N/A |
| 6/30/2016 | 482 | 141 | N/A | 147 | N/A |
| 3/31/2016 | 495 | 139 | N/A | 143 | N/A |
| 12/31/2015 | 507 | 137 | N/A | 140 | N/A |
| 9/30/2015 | 515 | 128 | N/A | 134 | N/A |
| 6/30/2015 | 522 | 120 | N/A | 129 | N/A |
| 3/31/2015 | 514 | 96 | N/A | 147 | N/A |
| 12/31/2014 | 506 | 71 | N/A | 165 | N/A |
| 9/30/2014 | 495 | 62 | N/A | 169 | N/A |
| 6/30/2014 | 484 | 52 | N/A | 173 | N/A |
| 3/31/2014 | 462 | 55 | N/A | 141 | N/A |
| 12/31/2013 | 439 | 58 | N/A | 108 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 157's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 157's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 157's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 157's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 157's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 157's Return on Equity is forecast to be high in 3 years time